4.6 Editorial Material

COVID-19 and management of neuroimmunological disorders

Journal

NATURE REVIEWS NEUROLOGY
Volume 16, Issue 7, Pages 347-348

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41582-020-0368-9

Keywords

-

Ask authors/readers for more resources

The importance of reported neurological manifestations of coronavirus disease 2019 (COVID-19) is still unclear. Nevertheless, an immediate and ongoing neurological challenge posed by the COVID-19 pandemic is the management of patients who are undergoing immunotherapy for existing neuroimmunological disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available